Skip to main content
Clinical Trials/NL-OMON24454
NL-OMON24454
Not yet recruiting
Not Applicable

The value of a risk prediction tool (PERSARC) for effective treatment decisions of soft tissue sarcomas patients: a stepped wedge Randomized Controlled Trial.

KWF kankerbestrijding0 sites231 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
grade 2-3 soft tissue extremity sarcoma
Sponsor
KWF kankerbestrijding
Enrollment
231
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
KWF kankerbestrijding

Eligibility Criteria

Inclusion Criteria

  • Patients (\>\= 18 years) with primarily diagnosed (histologically confirmed) grade 2\-3 extremity STS, who do not have a treatment plan yet and will be treated with curative intent. Patients with sarcoma subtypes or treatment options other than those mentioned in the PERSARC app are unable to participate. Furthermore, patients need to be Dutch fluency and literacy and mentally competent.

Exclusion Criteria

  • Patient that are treated without curative intent
  • Patient that needs to be treated with chemotherapy or isolated limb perfusion
  • Patients were surgery is not indicated
  • Sarcoma subtypes not mentioned in the PERSARC app

Outcomes

Primary Outcomes

Not specified

Similar Trials